Science and Risk-Based Commissioning, Qualification and Validation (CQV)

Join us for an insightful after-work event where we explore the fundamentals of Science and Risk-Based Commissioning, Qualification and Validation (CQV) and how these principles are applied in modern pharmaceutical projects. Through practical examples and real-life experiences, participants will gain a deeper understanding of how a science- and risk-based approach can improve project execution, strengthen compliance, and focus efforts where they create the greatest value.

The session will cover the key roles involved in CQV, including Engineering Responsible (ER), Operational Responsible (OR), Quality Assurance (QA), and Subject Matter Experts (SMEs). Particular attention will be given to the Engineering Responsible role, its responsibilities throughout the project lifecycle, and the critical success factors that contribute to successful project delivery.

Drawing on extensive industry experience, our speaker will share practical insights, lessons learned, and common challenges encountered during CQV activities in pharmaceutical manufacturing environments.

During the event, you will gain insights into:

• The fundamentals of Science and Risk-Based Validation (SRV) 
• How SRV principles are applied in pharmaceutical projects 
• Roles and responsibilities within the SRV framework, including ER, OR, QA, and SMEs 
• The Engineering Responsible role and its impact on project success 
• Common challenges, pitfalls, and best practices in CQV execution 
• Practical examples and lessons learned from real-world projects 

The event concludes with an interactive Q&A session, providing participants with the opportunity to discuss challenges, exchange experiences, and engage directly with the speaker.

Who should attend?

This event is relevant for professionals working within Commissioning, Qualification & Validation (CQV), Engineering, Project Management, Quality Assurance, Manufacturing, and Operations who want to strengthen their understanding of science- and risk-based approaches in pharmaceutical projects